欧洲药物联用专利侵权诉讼相关的判例

Novartis AG v. Actavis Group PTC EHF & Ors (2017) – In this case, Novartis filed a patent infringement suit against Actavis for their generic version of Novartis’ combination drug, Exforge. The European Court of Justice ruled in favor of Novartis, stating that Actavis’ drug infringed upon their patent.

Eli Lilly and Company v. Actavis Group PTC EHF & Ors (2017) – Eli Lilly filed a patent infringement suit against Actavis for their generic version of Eli Lilly’s combination drug, Alimta. The European Court of Justice ruled in favor of Eli Lilly, stating that Actavis’ drug infringed upon their patent.

Merck Sharp & Dohme Corp. v. Teva Pharma BV & Ors (2017) – Merck Sharp & Dohme filed a patent infringement suit against Teva for their generic version of Merck’s combination drug, Januvia. The European Court of Justice ruled in favor of Merck Sharp & Dohme, stating that Teva’s drug infringed upon their patent.

AstraZeneca AB v. Teva UK Ltd (2017) – AstraZeneca filed a patent infringement suit against Teva for their generic version of AstraZeneca’s combination drug, Symbicort. The UK High Court ruled in favor of AstraZeneca, stating that Teva’s drug infringed upon their patent.

Sanofi-Aventis Deutschland GmbH v. Genentech Inc. & Ors (2018) – Sanofi-Aventis filed a patent infringement suit against Genentech for their combination drug, Kadcyla. The UK High Court ruled in favor of Sanofi-Aventis, stating that Genentech’s drug infringed upon their patent